SAH GLOBAL DEVELOPING VISONS
SAH Global manages highly specialized investment projects within a variety of sectors, including communications, healthcare, energy and real estate. We target investment projects based on their long-term growth prospects, their use of cutting-edge technologies and their potential impact on the community as a whole.
There is a rapid increase of new cancer cases in Saudi Arabia, United Arab Emirates, Qatar, Oman, Kuwait, Bahrain and elsewhere in the Middle-East and North Africa, however, few have access to the treatment because of its limited availability. For a decade, going through the long and complex process of designing, building, and operating its own PET and Proton Therapy centers, SAH has thoroughly consulted numerous physicists, chemists, oncologists, pharmacists, biologists, engineers, technicians, manufacturers, architects, and specialists of nuclear medicine, radioprotection, safety, quality and more, to select the best options. Our team has gathered unparalleled experience in Designing, Building and Operating PET and Proton Therapy Centers.
PET & Molecular Imaging
In our continuous effort to positively impact cancer care in the Middle East and around the world, SAH Global will be exhibiting at Arab Health from 30 January – 2 February 2017. Come meet us at Sheikh Saeed Hall 3, Booth D75 Are you ready for...read more
SAH Global is pleased to announce its participation at the 2016 ASTRO Annual Meeting in Boston. As the exclusive regional distributor for VisionTree® Optimal Care (VTOC) platform Software in the MENA Region and the EU, SAH Global would like to invite healthcare...read more
SAH Global Partners with VisionTree to Improve Patient Outcomes Through Its Innovative Cloud Based Solution
SAH Inks Agreement to Distribute VisionTree® Software Throughout Middle East Region and the EU Riyadh, Saudi Arabia – 16th May 2016 Proton Therapy Pioneers SAH Global announced today at Saudi Health 2016, that they have signed a Collaboration and Exclusive...read more
SAH Global, a leader in establishing a network of Proton Therapy and Molecular Imaging Centers in the MENA region, exhibited their turnkey solutions at Arab Health and hosted the following workshops, including the first ever workshop on Proton Therapy to be held at...read more
SAH Global is the proud recipient of a letter of recommendation from former Ambassador of the United States to the Sultanate of Oman, the Honorable Greta C. Holtz. Ms. Holtz served as Ambassador to the Sultanate of Oman from 2012 to 2016 and during that time a...read more
Muscat, Oman – 1st October, 2015 – The Research Council of Oman signed today a Letter of Intent (LOI) with SAH Global to develop its SAH Oman PET & Proton center at the Innovation Park Muscat. (IPM). This represents the first Healthcare company the IPM has...read more
World leaders and innovators in the field of advanced cancer treatment gathered recently at a Proton Therapy Symposium held at the Jaber Al-Ahmed Armed Forces Hospital in Kuwait, sponsored by SAH. The symposium was held to foster discussion of the clinical...read more
Clinical leaders and world renowned physicians convened to discuss advanced cancer treatments at the Proton Therapy Symposium held at Ahmadi Hospital in Kuwait. The event, sponsored by SAH Global, was held to foster discussion of the clinical effectiveness of Proton...read more
Dr. Allan Thornton Delivers a Keynote Address at the 7th Muscat International Oncology & 4th Oman Cancer Association Conference
SAH experts were key presenters at the world’s leading oncology conference, the Muscat International Oncology & 4th Oman Cancer Association Conference, held in collaboration with the Gulf Federation for Cancer Control, the Indian Co-operative Oncology Network and...read more
Muscat, Oman – The SAH team scanned the first PET/CT patient ever in the Sultanate of Oman on Tuesday the 12th May, 2015. The scan was conducted at the Sultan Qaboos University Hospital (SQUH), where SAH was recently awarded the contract to commission and operate the...read more